HUTCHMED (China) Ltd Files Form 6-K

Ticker: HMDCF · Form: 6-K · Filed: Nov 22, 2024 · CIK: 1648257

Hutchmed (China) LTD 6-K Filing Summary
FieldDetail
CompanyHutchmed (China) LTD (HMDCF)
Form Type6-K
Filed DateNov 22, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: reporting, foreign-private-issuer, sec-filing

TL;DR

HUTCHMED (China) Ltd filed a 6-K on 11/22/24, standard reporting for foreign issuers.

AI Summary

HUTCHMED (China) Limited filed a Form 6-K on November 22, 2024, reporting information as of November 2024. The company, previously known as Hutchison China MediTech Ltd, is incorporated in E9 and has its principal executive offices in Hong Kong. This filing is a routine report for foreign private issuers.

Why It Matters

This filing indicates ongoing reporting requirements for HUTCHMED (China) Limited as a foreign private issuer, providing updates to the SEC and investors.

Risk Assessment

Risk Level: low — This filing is a routine report and does not contain specific financial or operational news that would inherently increase risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the issuer makes or is required to make public pursuant to the laws of its home country.

When was HUTCHMED (China) Limited previously known by another name?

The company was formerly known as Hutchison China MediTech Ltd, with a date of name change on July 16, 2015.

Where are HUTCHMED (China) Limited's principal executive offices located?

The principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.

Does HUTCHMED (China) Limited file annual reports under Form 20-F or 40-F?

The filing indicates that the registrant files annual reports under cover of Form 20-F.

What is the SIC code for HUTCHMED (China) Limited?

The Standard Industrial Classification (SIC) code for HUTCHMED (China) Limited is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 167 words · 1 min read · ~1 pages · Grade level 13.3 · Accepted 2024-11-22 06:04:42

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of Novem ber 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to HUTCHMED announces launch by Takeda of FRUZAQLA (fruquintinib) in Japan 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: November 22, 2024 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing